Suppr超能文献

口服柚皮苷(一种潜在的镇咳药)在大鼠和犬体内的代谢和排泄研究。

Metabolism and excretion studies of oral administered naringin, a putative antitussive, in rats and dogs.

机构信息

Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, PR China.

出版信息

Biopharm Drug Dispos. 2012 Apr;33(3):123-34. doi: 10.1002/bdd.1775. Epub 2012 Mar 17.

Abstract

Naringin, a major active flavonone glycoside from a traditional Chinese medicine Huajuhong, has been demonstrated to have activities such as peripheral antitussive, mucoregulator and anti-inflammatory. The purpose of this study was to elucidate the metabolism and mass balance of orally administered naringin in rats and dogs. After oral administration of naringin to rats and dogs at doses of 42 mg/kg and 12.4 mg/kg, respectively, metabolites in excreta were identified using a LC-Q-TOF system. The major metabolites including naringin, total naringenin (including free naringenin and its conjugates) and 4-hydroxyphenylpropionic acid in excreta were quantified by a LC-MS/MS system. Twenty-two metabolites were identified in dogs and 17 metabolites were detected in rats. The observed routes of naringin metabolism were hydroxylation, methylation, acetylation, hydrogenation, deglycosylation, dehydrogenation, glucuronidation, sulfation, glucosylation, ring-fission, oxidation, glycine conjugation and dehydroxylation. On the basis of these identified metabolites, a comprehensive metabolic pathway of naringin was proposed. About 21% of administered naringin was recovered in rat excreta in the form of naringin, total naringenin and 4-hydroxyphenylpropionic acid, and about 60% was recovered in dog excreta. The levels of 4-hydroxyphenylpropionic acid in excreta were higher than those of naringin and total naringenin, and the quantified metabolites were excreted more through feces, rather than urine. Most of these metabolites were excreted within 36 h post dose. The results of metabolism and excretion studies provide an explanation for future pharmacological and toxicological findings and are the groundwork for clinical studies.

摘要

柚皮苷是一种源自中药化橘红的主要活性黄酮糖苷,具有镇咳、黏膜修复和抗炎等作用。本研究旨在阐明柚皮苷在大鼠和犬体内的口服代谢和物质平衡。大鼠和犬分别以 42mg/kg 和 12.4mg/kg 的剂量口服给予柚皮苷后,采用 LC-Q-TOF 系统鉴定排泄物中的代谢物。采用 LC-MS/MS 系统定量测定排泄物中的主要代谢物,包括柚皮苷、总柚皮素(包括游离柚皮素及其缀合物)和 4-羟基苯丙酸。在犬体内鉴定出 22 种代谢物,在大鼠体内检测到 17 种代谢物。观察到的柚皮苷代谢途径包括羟化、甲基化、乙酰化、氢化、去糖基化、脱氢、葡萄糖醛酸化、硫酸化、葡萄糖苷化、环裂、氧化、甘氨酸缀合和去羟化。基于这些鉴定出的代谢物,提出了柚皮苷的综合代谢途径。大鼠排泄物中以柚皮苷、总柚皮素和 4-羟基苯丙酸形式回收的给药柚皮苷约为 21%,犬排泄物中回收的给药柚皮苷约为 60%。排泄物中 4-羟基苯丙酸的水平高于柚皮苷和总柚皮素,且定量代谢物主要通过粪便排泄,而非尿液。这些代谢物大部分在给药后 36 小时内排泄。代谢和排泄研究的结果为未来的药理学和毒理学发现提供了解释,并为临床研究奠定了基础。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验